Showing results (71-80 of 76) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 76 results.
Therapeutic Advances in Medical Oncology|July 2, 2021
External validity of clinical trials with diverse trastuzumab-based chemotherapy regimens in advanced gastroesophageal adenocarcinoma: data from the AGAMENON-SEOM registryPaula Jimenez-Fonseca, Alberto Carmona-Bayonas, Alba Martinez-Torron, et al.
Thrombosis and Haemostasis|August 29, 2019
Multistate Models: Accurate and Dynamic Methods to Improve Predictions of Thrombotic Risk in Patients with CancerAlberto Carmona-Bayonas, Paula Jimenez-Fonseca, Marcelo Garrido, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|September 24, 2020
External validity of docetaxel triplet trials in advanced gastric cancer: are there patients who still benefit?Paula Jimenez-Fonseca, Alberto Carmona-Bayonas, Eva Martínez de Castro, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|March 2, 2021
Is advanced esophageal adenocarcinoma a distinct entity from intestinal subtype gastric cancer? Data from the AGAMENON-SEOM RegistryFelipe Alvarez-Manceñido, Paula Jimenez-Fonseca, Alberto Carmona-Bayonas, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|February 16, 2024
Is there a preferred platinum and fluoropyrimidine regimen for advanced HER2-negative esophagogastric adenocarcinoma? Insights from 1293 patients in AGAMENON-SEOM registryAranzazu Arias-Martinez, Eva Martínez de Castro, Javier Gallego, et al.
Therapeutic Advances in Medical Oncology|March 10, 2023
The AGAMENON-SEOM model for prediction of survival in patients with advanced HER2-positive oesophagogastric adenocarcinoma receiving first-line trastuzumab-based therapyPaula Jimenez-Fonseca, Victoria Foy, Sophie Raby, et al.
Pageof 8